Göpel, Siri http://orcid.org/0000-0002-7666-4634
Bethge, Wolfgang
Martus, Peter
Kreth, Florian
Iftner, Thomas
Joos, Stefanie
Döbele, Stefanie
Mordmüller, Benjamin
Kremsner, Peter
Ettrich, Thomas
Seufferlein, Thomas
Bitzer, Michael
Malek, Nisar
Funding for this research was provided by:
Ministerium für Soziales und Integration, Baden-Württemberg
Article History
Received: 22 June 2020
Accepted: 24 June 2020
First Online: 10 July 2020
Ethics approval and consent to participate
: I hereby declare that the study has received ethical approval from the appropriate ethical committee: Ethik-Kommission an der Medizinischen Fakultät der Eberhard-Karls-Universität und am Universitätsklinikum Tübingen, Gartenstraße 47, 72074 Tübingen File number: 250/2020AMG1 Date: 20.04.2020.Written informed consent is obtained from all patients before study inclusion. The informed consent form was also approved by the ethics committee mentioned above. It contains detailed information about the study purpose, study design, the course of the disease, effects and side effects of Hydroxychloroquine. Patients are informed that participation in the study is voluntary and withdrawal can be done at any time.
: Not applicable.
: The authors declare that they have no competing interests.